SoftOx Solutions AS (SoftOx) has previously been refused on a request for a transitional arrangement from theNorwegian Environment Agency for its hand disinfection products. In this context, the company has requested an assessment and a clarifying statement from theEuropean Commission . Will be able to deliver on the National Hospital Tender (HINAS) and European markets The company's interpretation of the Biocidal Regulations is in line with the Commission's statement regarding the possible transitional arrangements for the company's hand and surface disinfectants. "This is very good news for SoftOx. In our opinion theEuropean Commission's assessment will enable us to make our products available on the market and we will be able to fulfil our obligations in accordance with the HINAS agreement. TheEuropean Commission's analysis and assessment means that SoftOx can, if the company wants to, go to all European markets with its disinfectant products for hand and surface", says CEOGeir Almås . "We are ready to meet increased demand" The company have a pending application in process in theNorwegian Environment Agency for approval of the company's hand and surface disinfection products. The transitional arrangement described by theEU Commission gives the company the opportunity to have the hand and surface products on the market until final approval of the pending application is available. "This is a scenario we have prepared for by buying 50 percent ofOse Water . We are ready to meet potential increased demand from major European markets", according to Almås. For further information, please contact: CEOGeir Almås ofSoftOx Solutions AS , or CFOKristine M. Rød ofSoftOx Solutions AS Mail: ir@soft-ox.com Mobile: (+47) 948 59 599 The information included in this announcement is defined as inside information pursuant to MAR article 7, and is publicly disclosed in accordance with MAR article 17. The announcement is made by the contact person. AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian BioTech company based inOslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com.
Click here for more information
© Oslo Bors ASA, source